Optimi Health Earnings Call Transcripts

Fiscal Year 2026

H.C. Wainwright 28th Annual Global Investment Conference

Currently commercial with psilocybin and MDMA products in Australia and Canada, the company is expanding globally as regulatory frameworks evolve. With a regulatory-first approach and strong financial backing, it is positioned as a leader in natural psychedelic manufacturing.

Read full transcript →